Skip to content
10-Q

Quarterly Report

SQZ BIOTECHNOLOGIES COMPANY

0000950170-22-023879

← back to feed
Filed
Nov 9, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 3, 2022 29.45M sh
Cash And Equivalents Q3 2022 · Sep 30, 2022 $84.24M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $143.51M
Current Liabilities Q3 2022 · Sep 30, 2022 $25.26M
Current Liabilities Q3 2022 · Dec 31, 2021 $33.22M
Total Liabilities Q3 2022 · Sep 30, 2022 $86.28M
Total Liabilities Q3 2022 · Dec 31, 2021 $102.18M
Current Assets Q3 2022 · Sep 30, 2022 $87.34M
Current Assets Q3 2022 · Dec 31, 2021 $150.64M
Total Assets Q3 2022 · Sep 30, 2022 $154.85M
Total Assets Q3 2022 · Dec 31, 2021 $226.15M
Shares Diluted Q3 2022 · Sep 30, 2021 28.05M sh
Shares Diluted Q3 2022 · Sep 30, 2021 27.42M sh
Capex Q3 2022 · Sep 30, 2021 $613K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$61.12M
Stockholders Equity Q3 2022 · Sep 30, 2021 $133.21M
Stockholders Equity Q3 2022 · Jun 30, 2021 $152.7M
Stockholders Equity Q3 2022 · Dec 31, 2020 $127.2M
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.80
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.08
Eps Basic Q3 2022 · Sep 30, 2021 −$0.80
Eps Basic Q3 2022 · Sep 30, 2021 −$2.08
Sga Expense Q3 2022 · Sep 30, 2021 $6.69M
Sga Expense Q3 2022 · Sep 30, 2021 $18.74M
Rd Expense Q3 2022 · Sep 30, 2021 $20.52M
Rd Expense Q3 2022 · Sep 30, 2021 $52.94M
Net Income Q3 2022 · Sep 30, 2021 −$22.45M
Net Income Q3 2022 · Sep 30, 2021 −$56.92M
Operating Income Q3 2022 · Sep 30, 2021 −$22.46M
Operating Income Q3 2022 · Sep 30, 2021 −$56.94M